Trial Details
NULLBasic Information
| Clinical ID | c4766 |
|---|---|
| Identifier | KCT0006087 |
| Trial Title | Efficacy and Safety of vedolizumab in biologic-name Korean patients with moderate to severe inflammatory bowel disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NULL |
|---|---|
| Conditions | ;Diseases of the digestive system |
| Interventions | Drug : The subjects to be recruited consist of 30 patients with Crohn's disease and 30 patients with ulcerative colitis (considering dropout rate of 20%). Crohn's disease (CD): If a subject does not respond to vedolizumab 300mg iv 0, 2, and 6 weeks fo |
Participant Information
| Sponsor | Yonsei University Health System, Severance Hospital |
|---|---|
| City | NULL |
| Country/Region | South Korea |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | Interventional Study |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |